IDYA
Price
$34.75
Change
-$1.03 (-2.88%)
Updated
Sep 18 closing price
55 days until earnings call
KALV
Price
$10.69
Change
+$0.12 (+1.14%)
Updated
Sep 18 closing price
77 days until earnings call
Ad is loading...

IDYA vs KALV

Header iconIDYA vs KALV Comparison
Open Charts IDYA vs KALVBanner chart's image
IDEAYA Biosciences
Price$34.75
Change-$1.03 (-2.88%)
Volume$490.51K
CapitalizationN/A
KalVista Pharmaceuticals
Price$10.69
Change+$0.12 (+1.14%)
Volume$249.37K
CapitalizationN/A
View a ticker or compare two or three
IDYA vs KALV Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KALV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
IDYA vs. KALV commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and KALV is a StrongSell.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (IDYA: $34.77 vs. KALV: $10.67)
Brand notoriety: IDYA and KALV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 74% vs. KALV: 70%
Market capitalization -- IDYA: $2.94B vs. KALV: $456.79M
IDYA [@Biotechnology] is valued at $2.94B. KALV’s [@Biotechnology] market capitalization is $456.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $599.73B to $0. The average market capitalization across the [@Biotechnology] industry is $3.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 1 FA rating(s) are green whileKALV’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 1 green, 4 red.
  • KALV’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than KALV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 3 TA indicator(s) are bullish while KALV’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 3 bullish, 5 bearish.
  • KALV’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both IDYA and KALV are a bad buy in the short-term.

Price Growth

IDYA (@Biotechnology) experienced а -3.95% price change this week, while KALV (@Biotechnology) price change was -0.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.99%. For the same industry, the average monthly price growth was +1.54%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

IDYA is expected to report earnings on Nov 13, 2024.

KALV is expected to report earnings on Dec 05, 2024.

Industries' Descriptions

@Biotechnology (+0.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.94B) has a higher market cap than KALV($457M). IDYA YTD gains are higher at: -2.277 vs. KALV (-12.898). KALV has higher annual earnings (EBITDA): -131.18M vs. IDYA (-187.16M). IDYA has more cash in the bank: 702M vs. KALV (210M). IDYA has less debt than KALV: IDYA (1.87M) vs KALV (7.32M). IDYA has higher revenues than KALV: IDYA (12M) vs KALV (0).
IDYAKALVIDYA / KALV
Capitalization2.94B457M643%
EBITDA-187.16M-131.18M143%
Gain YTD-2.277-12.89818%
P/E RatioN/AN/A-
Revenue12M0-
Total Cash702M210M334%
Total Debt1.87M7.32M26%
FUNDAMENTALS RATINGS
KALV: Fundamental Ratings
KALV
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAKALV
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 21 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
68%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KALV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSFAX26.890.05
+0.19%
Federated Hermes Clover Small Value A
SFILX13.76N/A
N/A
Schwab Fundamental Intl Sm Eq Idx
PAGSX64.84-0.02
-0.03%
T. Rowe Price Global Stock Adv
EFCCX17.92-0.06
-0.33%
Emerald Insights C
QILGX34.78-0.13
-0.37%
Federated Hermes MDT Large Cap Growth IS

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-2.82%
GRI - IDYA
54%
Loosely correlated
-2.84%
INAB - IDYA
47%
Loosely correlated
+1.15%
SNDX - IDYA
45%
Loosely correlated
-0.33%
KALV - IDYA
42%
Loosely correlated
+0.95%
NTLA - IDYA
42%
Loosely correlated
-0.13%
More

KALV and

Correlation & Price change

A.I.dvisor indicates that over the last year, KALV has been loosely correlated with IDYA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KALV jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALV
1D Price
Change %
KALV100%
+0.95%
IDYA - KALV
42%
Loosely correlated
-2.82%
ATXS - KALV
42%
Loosely correlated
+1.22%
PLRX - KALV
41%
Loosely correlated
-0.79%
FATE - KALV
41%
Loosely correlated
-3.00%
FOLD - KALV
41%
Loosely correlated
-2.59%
More